DE602004004259D1 - (6-(PHENOXY)-PYRIDOi3,4-DöPYRIMIDIN-2-YL)-AMIN DERIVATE ALS P38 KINASE INHIBITOREN ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN WIE RHEUMATOIDER ARTHRITIS - Google Patents
(6-(PHENOXY)-PYRIDOi3,4-DöPYRIMIDIN-2-YL)-AMIN DERIVATE ALS P38 KINASE INHIBITOREN ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN WIE RHEUMATOIDER ARTHRITISInfo
- Publication number
- DE602004004259D1 DE602004004259D1 DE602004004259T DE602004004259T DE602004004259D1 DE 602004004259 D1 DE602004004259 D1 DE 602004004259D1 DE 602004004259 T DE602004004259 T DE 602004004259T DE 602004004259 T DE602004004259 T DE 602004004259T DE 602004004259 D1 DE602004004259 D1 DE 602004004259D1
- Authority
- DE
- Germany
- Prior art keywords
- dopyrimidin
- pyridoi3
- phenoxy
- treatment
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46322903P | 2003-04-16 | 2003-04-16 | |
US463229P | 2003-04-16 | ||
PCT/EP2004/003883 WO2004091625A1 (en) | 2003-04-16 | 2004-04-13 | (6-(phenoxy)-pyrido`3,4-d! pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602004004259D1 true DE602004004259D1 (de) | 2007-02-22 |
DE602004004259T2 DE602004004259T2 (de) | 2007-11-15 |
Family
ID=33300055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004004259T Expired - Fee Related DE602004004259T2 (de) | 2003-04-16 | 2004-04-13 | (6-(PHENOXY)-PYRIDOi3,4-DöPYRIMIDIN-2-YL)-AMIN DERIVATE ALS P38 KINASE INHIBITOREN ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN WIE RHEUMATOIDER ARTHRITIS |
Country Status (16)
Country | Link |
---|---|
US (2) | US7189731B2 (de) |
EP (1) | EP1620105B1 (de) |
JP (1) | JP2006523640A (de) |
KR (1) | KR20060006037A (de) |
CN (1) | CN1774250A (de) |
AR (1) | AR044515A1 (de) |
AU (1) | AU2004229163A1 (de) |
BR (1) | BRPI0409405A (de) |
CA (1) | CA2520785A1 (de) |
CL (1) | CL2004000805A1 (de) |
DE (1) | DE602004004259T2 (de) |
ES (1) | ES2279361T3 (de) |
MX (1) | MXPA05010975A (de) |
RU (1) | RU2005135329A (de) |
TW (1) | TW200503722A (de) |
WO (1) | WO2004091625A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
US20090131430A1 (en) * | 2004-11-23 | 2009-05-21 | Palle Venkata P | Pyrido'2,3-dipyrimidines as anti-inflammatory agents |
ES2303758B1 (es) * | 2006-02-20 | 2009-08-13 | Laboratorios Almirall S.A. | Nuevos derivados de piridin-3-amina. |
EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
CA2754808C (en) | 2009-03-11 | 2019-01-08 | Auckland Uniservices Limited | Prodrug forms of kinase inhibitors and their use in therapy |
NZ598144A (en) * | 2009-09-02 | 2014-01-31 | Auckland Uniservices Ltd | Kinase inhibitors, prodrug forms thereof and their use in therapy |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1199768A (en) * | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
JPS4936700A (de) * | 1972-08-16 | 1974-04-05 | ||
US4672116A (en) * | 1985-12-20 | 1987-06-09 | Ortho Pharmaceutical Corporation | Substituted 5,6-dialkoxyquinazoline derivatives |
US5084463A (en) * | 1989-12-11 | 1992-01-28 | American Home Products Corporation | N-quinolinyl alkyl-substituted 1-aryloxy-2-propanolamine and propylamine derivatives possessing class III antiarrhythmic activity |
US20020061879A1 (en) * | 1996-02-02 | 2002-05-23 | Garvey David S. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
US6248771B1 (en) | 1997-03-05 | 2001-06-19 | Sugen, Inc. | Formulations for hydrophobic pharmaceutical agents |
US6313294B1 (en) * | 1998-02-04 | 2001-11-06 | Development Center For Biotechnology | Process for preparing amides |
EP1230225A2 (de) | 1999-11-01 | 2002-08-14 | Eli Lilly And Company | Pharmazeutisch wirksame 4-substituierte pyrimidine derivate |
WO2001038315A1 (en) | 1999-11-22 | 2001-05-31 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
EP1110552A1 (de) | 1999-12-22 | 2001-06-27 | Aventis Pharma S.A. | Verwendung einer Verbingung mit hoher Affinität für den mitochondrialen Benzodiazepin Rezeptor in einem Arzneimittel zur Krebs-Therapie |
US6605615B2 (en) | 2000-03-01 | 2003-08-12 | Tularik Inc. | Hydrazones and analogs as cholesterol lowering agents |
CA2417192A1 (en) | 2000-07-26 | 2002-01-31 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
ATE305303T1 (de) * | 2001-02-12 | 2005-10-15 | Hoffmann La Roche | 6-substituierte pyridopyrimidine |
DE60231868D1 (de) | 2001-04-24 | 2009-05-20 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
WO2002090360A1 (en) * | 2001-05-10 | 2002-11-14 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
RU2324695C2 (ru) * | 2002-08-06 | 2008-05-20 | Ф.Хоффманн-Ля Рош Аг | 6-АЛКОКСИПИРИДОПИРИМИДИНЫ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ ИНГИБИТОРОВ КИНАЗЫ МАР р38 |
-
2004
- 2004-04-13 AU AU2004229163A patent/AU2004229163A1/en not_active Abandoned
- 2004-04-13 ES ES04726958T patent/ES2279361T3/es not_active Expired - Lifetime
- 2004-04-13 CN CNA2004800099562A patent/CN1774250A/zh active Pending
- 2004-04-13 EP EP04726958A patent/EP1620105B1/de not_active Expired - Lifetime
- 2004-04-13 DE DE602004004259T patent/DE602004004259T2/de not_active Expired - Fee Related
- 2004-04-13 MX MXPA05010975A patent/MXPA05010975A/es not_active Application Discontinuation
- 2004-04-13 BR BRPI0409405-0A patent/BRPI0409405A/pt not_active Application Discontinuation
- 2004-04-13 JP JP2006505106A patent/JP2006523640A/ja active Pending
- 2004-04-13 RU RU2005135329/04A patent/RU2005135329A/ru not_active Application Discontinuation
- 2004-04-13 WO PCT/EP2004/003883 patent/WO2004091625A1/en active IP Right Grant
- 2004-04-13 CA CA002520785A patent/CA2520785A1/en not_active Abandoned
- 2004-04-13 KR KR1020057019705A patent/KR20060006037A/ko not_active Application Discontinuation
- 2004-04-15 US US10/824,980 patent/US7189731B2/en not_active Expired - Fee Related
- 2004-04-15 AR ARP040101263A patent/AR044515A1/es unknown
- 2004-04-15 CL CL200400805A patent/CL2004000805A1/es unknown
- 2004-04-15 TW TW093110567A patent/TW200503722A/zh unknown
-
2007
- 2007-01-09 US US11/651,320 patent/US20070135459A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2279361T3 (es) | 2007-08-16 |
CA2520785A1 (en) | 2004-10-28 |
MXPA05010975A (es) | 2005-11-28 |
BRPI0409405A (pt) | 2006-04-25 |
EP1620105B1 (de) | 2007-01-10 |
CL2004000805A1 (es) | 2005-02-04 |
WO2004091625A1 (en) | 2004-10-28 |
US20070135459A1 (en) | 2007-06-14 |
AU2004229163A1 (en) | 2004-10-28 |
DE602004004259T2 (de) | 2007-11-15 |
CN1774250A (zh) | 2006-05-17 |
TW200503722A (en) | 2005-02-01 |
US20040209903A1 (en) | 2004-10-21 |
AR044515A1 (es) | 2005-09-14 |
KR20060006037A (ko) | 2006-01-18 |
RU2005135329A (ru) | 2006-08-10 |
US7189731B2 (en) | 2007-03-13 |
JP2006523640A (ja) | 2006-10-19 |
EP1620105A1 (de) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006010243D1 (de) | 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen | |
MEP52808A (en) | Aminoheteroaryl compounds as protein kinase inhibitors | |
NZ542616A (en) | P38 inhibitors and methods of use thereof | |
ATE517896T1 (de) | P38-kinase-inhibitoren | |
CY1110746T1 (el) | Ετεροαρωματικες ενωσεις κινολινης και χρηση αυτων ως αναστολεις pde10 | |
MY140291A (en) | Sulfoximine-substituted pyrimidines for use as cd and/or vegf inhibitors, the production thereof and their use as drugs | |
CY1109006T1 (el) | Παραγωγα πουρινης ως αναστολεις κινασης | |
ATE473980T1 (de) | Triazolopyridazine als proteinkinase-inhibitoren | |
ATE406351T1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
SE0301372D0 (sv) | Novel compounds | |
DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
DK1633726T3 (da) | Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme | |
SE0301373D0 (sv) | Novel compounds | |
ATE420879T1 (de) | Indolizine als kinaseproteinhemmer | |
DE60332396D1 (de) | PYRAZOLOi3,4-B PYRIDINVERBINDUNGEN UND IHRE VERWENDUNG ALS PHOSPHODIESTERASE INHIBITOREN | |
ATE529406T1 (de) | Aryl-harnstoffe als kinase inhibitoren | |
MX2007001289A (es) | Piridinas condensadas como inhibidores de cinasa. | |
EA200970738A1 (ru) | Ингибиторы активности akt | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
CY1105686T1 (el) | 2-(ΠΥΡΙΔΙΝ-2-ΥΛΑΜΙΝΟ)-ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΥΝ-7-ΟΝΕΣ | |
NO20070453L (no) | Kondenserte heterocykliske kinase inhibitorer | |
DE60315146D1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
NL1027811A1 (nl) | Heterocyclische aminen als remmers 11- -hydroxy-steroïd-dehydrogenase type 1. | |
DK1648905T3 (da) | Inhibitorer for thienopyridin- og furopyridinkinase | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |